also
known
dipeptidyl
peptidas
dppiv
multifunct
highli
glycosyl
integr
type
ii
transmembran
protein
involv
varieti
biolog
wide
express
epitheli
endotheli
cell
differ
tissu
express
strongli
upregul
activ
cell
b
cell
natur
killer
nk
serin
proteas
cleav
peptid
select
prolin
alanin
penultim
posit
substrat
modul
biolog
activ
divers
rang
bioactiv
peptid
chemokin
peptid
hormon
neuropeptid
indic
substrat
addit
peptidas
activ
mediat
cell
adhes
interact
fibronectin
moreov
play
crucial
role
immun
costimul
involv
tcell
activ
differenti
interact
molecul
essenti
cellular
function
tcell
respons
adenosin
deaminas
owe
multidisciplinari
characterist
report
relat
divers
differ
diseas
diabet
mellitu
hiv
infect
cardiovascular
diseas
autoimmun
diseas
inhibit
dppiv
activ
could
alter
express
immun
responserel
gene
truncat
certain
chemokin
may
affect
certain
function
cell
immun
respons
play
potenti
role
differ
process
crucial
inflamm
reaction
transplant
reject
well
wound
heal
dppiv
inhibitor
recent
emerg
antidiabet
drug
reduct
blood
glucos
inhibit
rapid
degrad
incretin
hormon
glucagonlik
gastric
inhibitori
furthermor
also
suggest
therapeut
target
diseas
chronic
kidney
diseas
middl
east
respiratori
syndrom
coronaviru
infect
graftversushost
diseas
gvhd
annual
million
peopl
suffer
burn
injuri
skin
transplant
one
import
approach
treat
largearea
burn
howev
skin
transplant
also
present
one
challeng
clinic
treatment
longterm
surviv
allogen
xenogen
skin
graft
difficult
achiev
clinic
therapi
immun
reject
skin
transplant
dendrit
cell
donor
skin
migrat
graft
present
donor
antigen
recogn
recipi
cell
follow
allorecognit
recipi
cell
becom
activ
prolifer
secret
proinflammatori
cytokin
secret
differ
tcell
subset
play
crucial
role
activ
effector
cell
inflammatori
stage
initi
effector
cell
macrophag
arriv
graft
site
destroy
sever
observ
indic
contribut
process
transplant
reject
first
act
import
activ
marker
helper
cell
associ
earli
stage
transplant
second
recent
studi
suggest
potenti
posit
marker
interleukin
il
cell
neg
marker
regulatori
cell
treg
balanc
treg
critic
allograft
reject
immunolog
moreov
recent
studi
report
strong
express
associ
organ
understand
role
particularli
molecular
mechan
allogen
graft
reject
crucial
develop
novel
strategi
inhibit
graft
reject
improv
therapeut
effect
clinic
organ
transplant
present
studi
compar
allogen
graft
reject
mice
tailskin
transplant
measur
percentag
lymphocyt
subset
spleen
blood
mice
pretransplant
posttransplant
analyz
secret
level
cytokin
antibodi
mice
sera
result
demonstr
defici
result
delay
reduc
graft
immun
reject
murin
allogen
skin
transplant
donor
mice
male
balbc
mice
recipi
mice
homozyg
mice
n
genet
wildtyp
mice
mice
kept
specif
pathogenfre
condit
experi
perform
male
femal
sexrel
differ
anim
treat
accord
german
law
protect
anim
permiss
obtain
state
anim
welfar
committe
prepar
tail
skin
donor
mice
donor
mice
sacrif
entir
tail
swab
ethanol
tail
skin
donor
incis
area
recipi
mice
anesthet
isofluran
inhal
circumferenti
band
shave
back
recipi
mice
shave
back
clean
ethanol
allow
dri
back
skin
recipi
mice
cut
graft
bed
bed
skin
remov
recipi
skin
graft
place
graft
bed
four
corner
graft
stitch
mice
wrap
bandag
mice
place
clean
cage
heat
red
lamp
move
freeli
seven
day
transplant
bandag
remov
skin
graft
monitor
daili
record
photograph
day
skin
reject
score
base
necrot
area
wrinkl
skin
skin
graft
necrot
area
roughli
estim
visual
inspect
six
differ
score
level
defin
accord
percentag
necrot
area
graft
fulli
intact
smooth
graft
graft
necrot
area
score
necrot
area
score
necrot
area
score
necrot
area
score
remov
score
sampl
graft
fulli
remov
score
msl
isol
publish
separ
mpbl
peripher
blood
collect
minicollect
tube
greiner
bioon
austria
erythrocyt
lyse
lyse
solut
bd
facstm
lyse
solut
follow
antibodi
stain
subpopul
lymphocyt
measur
flow
cytometri
mice
monoclon
antibodi
mab
use
multiparamet
flow
cytometr
analysi
allophycocyanin
apc
conjug
phycoerythrin
pe
conjug
fluorescein
isothiocyan
fitc
conjug
fitcconjug
peconjug
peconjug
obtain
biolegend
london
unit
kingdom
peconjug
apcconjug
provid
immunotool
friesoyth
germani
lymphocyt
incub
antibodi
wv
bovin
serum
albuminphosphatebuff
salin
pb
h
dark
cell
wash
twice
pb
analyz
flow
cytometri
bd
bioscienc
softwar
use
analyz
percentag
differ
lymphocyt
subpopul
blood
sampl
collect
mous
tail
clot
h
room
temperatur
centrifug
sera
transfer
new
tube
store
analysi
quantifi
serum
ig
use
enzymelink
immunosorb
assay
elisa
describ
previous
briefli
antimous
ig
polyclon
antibodi
immunotool
friesoyth
germani
use
coat
ab
igg
biotinlabel
antimous
igg
mab
bd
pharmingen
use
detect
ab
interleukin
concentr
serum
determin
elisa
kit
ebiosci
interferon
ifn
r
system
biolegend
procedur
perform
accord
instruct
provid
correspond
manufactur
tailskin
transplant
skin
graft
recipi
mice
collect
day
transplant
place
onto
prelabel
tissu
base
mold
entir
tissu
block
cover
optim
cut
temperatur
compound
tissu
block
store
within
month
readi
section
desir
thick
frozen
section
frozensect
cut
tissu
section
fix
precool
aceton
min
wash
pb
tissu
section
first
incub
primari
ab
overnight
wash
pb
section
incub
fitclabel
secondari
ab
h
follow
wash
step
section
incub
hoechst
thermo
fisher
scientif
nuclear
stain
ab
use
present
experi
rat
antimous
monoclon
ab
mgml
r
system
mgml
biolegend
mgml
biolegend
mgml
immunotool
tissu
donor
mice
serv
control
data
obtain
three
independ
experi
valu
repres
mean
sd
least
seven
mice
group
signific
differ
mice
mice
calcul
anovaanalysi
differ
group
consid
signific
p
p
p
p
mice
mice
transplant
balbc
tail
skin
n
per
group
seven
day
transplant
bandag
remov
necrot
area
black
spot
skin
graft
monitor
daili
record
photograph
day
posttransplant
fig
six
differ
score
level
defin
accord
necrot
area
mous
skin
graft
posttransplant
fig
statist
analysi
indic
necrot
level
skin
graft
lower
mice
mice
day
day
fig
graft
reject
mice
significantli
slower
mice
p
fig
find
suggest
involv
graft
reject
understand
underli
molecular
mechan
allogen
graft
reject
product
igg
well
mice
serum
differ
time
point
measur
elisa
skin
transplant
product
antibodi
mice
serum
elev
rapidli
day
posttransplant
fig
product
level
igg
mice
highest
day
maximum
product
reach
day
posttransplant
howev
day
posttransplant
concentr
level
serum
igg
mice
significantli
lower
mice
concentr
igg
mice
higher
mice
vs
p
vs
p
day
respect
fig
analysi
demonstr
concentr
igg
isotyp
also
remark
lower
mice
particular
level
day
serum
mice
approxim
serum
mice
vs
vs
respect
fig
c
result
suggest
delay
insuffici
immun
respons
mice
allogen
transplant
clarifi
mice
produc
lower
igg
skin
transplant
prolifer
differenti
lymphocyt
type
mice
investig
highest
distinct
secret
igg
observ
day
posttransplant
percentag
differ
lymphocyt
subpopul
mpbl
msl
mice
mice
day
ie
transplant
skin
transplant
measur
transplant
percentag
cell
mpbl
msl
mice
lower
mice
percentag
differ
significantli
two
mice
type
fig
howev
rel
pretransplant
percentag
cell
mpbl
increas
cell
decreas
mice
type
day
posttransplant
fig
indic
prolifer
lymphocyt
skin
transplant
nevertheless
signific
chang
detect
percentag
cell
pretransplant
posttransplant
interestingli
percentag
cell
show
signific
differ
mpbl
mice
skin
transplant
howev
day
posttransplant
cell
mpbl
lower
mpbl
vs
p
indic
reduc
activ
prolifer
cell
mice
respons
allogen
transplant
msl
percentag
differ
two
type
mice
decreas
posttransplant
compar
pretransplant
level
mice
percentag
cell
lower
mice
transplant
signific
percentag
differ
cell
mice
could
found
posttransplant
shown
mice
present
lower
percentag
cell
mpbl
msl
skin
transplant
lower
percentag
cell
mpbl
skin
transplant
investig
necessari
clarifi
differenti
effect
lymphocyt
subpopul
mice
skin
transplant
purpos
cytokin
secret
serv
specif
signal
lymphocyt
differenti
effect
determin
skin
transplant
cytokin
level
serum
differ
time
point
analyz
elisa
figur
show
measur
cytokin
secret
skin
transplant
concentr
cytokin
peak
day
posttransplant
except
peak
day
posttransplant
notabl
level
cytokin
fig
b
serum
mice
much
lower
serum
mice
day
posttransplant
level
serum
mice
onethird
serum
mice
pgml
vs
pgml
level
serum
mice
approxim
serum
mice
find
suggest
reduc
differenti
function
cell
mice
allogen
skin
transplant
interestingli
level
differ
cytokin
serum
mice
differ
compar
serum
mice
level
fig
serum
mice
significantli
lower
serum
mice
pgml
vs
pgml
day
posttransplant
p
level
fig
mice
markedli
lower
mice
pgml
vs
pgml
day
posttransplant
p
contrast
concentr
serum
type
mice
show
signific
differ
fig
concentr
mice
day
posttransplant
higher
mice
fig
notabl
level
serum
mice
day
skin
transplant
significantli
lower
serum
mice
day
concentr
mice
onethird
mice
find
suggest
differ
differenti
immun
respons
cell
mice
allogen
skin
transplant
given
essenti
differenti
cell
subpopul
import
role
subpopul
play
inflamm
amount
typic
cytokin
determin
elisa
releas
serum
type
mice
increas
peak
day
transplant
fig
level
significantli
lower
serum
mice
day
transplant
concentr
mice
mice
pgml
vs
pgml
day
level
reduc
mice
pgml
vs
pgml
percentag
cell
secret
cell
cell
mpbl
compar
two
mice
type
transplant
percentag
cell
cell
mice
nearli
half
mice
vs
p
day
transplant
fig
given
balanc
treg
critic
allograft
reject
immunolog
toler
express
biomark
treg
analyz
flow
cytometri
found
percentag
peripher
blood
spleen
exhibit
differ
mice
transplant
left
panel
fig
c
howev
day
posttransplant
percentag
cell
cell
mpbl
nearli
twofold
mice
vs
percentag
cell
msl
higher
msl
vs
right
panel
fig
c
consist
data
day
posttransplant
percentag
cell
cell
mpbl
higher
mpbl
vs
percentag
cell
subpopul
msl
higher
msl
vs
right
panel
fig
c
data
suggest
defici
result
reduc
differenti
cell
cell
increas
differenti
cell
treg
could
contribut
immun
toler
retard
graft
reject
mice
observ
allogen
transplant
infiltr
macrophag
cell
graft
tissu
mice
determin
immunohistofluoresc
analysi
graft
tissu
mice
cluster
macrophag
detect
day
transplant
fig
howev
frequenc
cluster
graft
mice
obvious
lower
area
cluster
graft
mice
rel
smaller
number
macrophag
graft
mice
significantli
less
graft
mice
suggest
reduc
infiltr
macrophag
graft
mice
fig
infiltr
lymphocyt
also
found
graft
type
mice
day
posttransplant
fig
shown
number
infiltr
cell
mice
clearli
less
mice
day
skin
transplant
fig
analysi
show
tcell
subset
cell
cell
infiltr
graft
tissu
two
type
mice
skin
transplant
number
infiltr
cell
type
particularli
cell
less
distinct
mice
mice
fig
howev
obviou
infiltr
b
lymphocyt
detect
either
type
mous
skin
transplant
data
shown
find
effect
way
inhibit
immun
reject
one
import
strategi
support
clinic
transplant
recent
studi
concern
organ
transplant
demonstr
applic
dppiv
inhibitor
mab
increas
engraft
donor
cell
decreas
acut
gvhd
respect
indic
novel
target
therapeut
intervent
gvhd
clarifi
role
allogen
graft
reject
knockout
mice
use
allogen
skin
transplant
studi
found
mice
present
lower
necrot
degre
graft
delay
allograft
reject
fig
activ
marker
b
lymphocyt
nk
cell
costimulatori
molecul
mediat
tcell
signal
transduct
process
interact
adenosin
deaminas
blockad
tcell
costimul
induc
anergi
present
work
lower
percentag
well
cell
found
mpbl
msl
mice
pre
postskin
transplant
fig
addit
infiltr
cell
detect
lower
degre
graft
tissu
mice
mice
skin
transplant
fig
c
find
indic
defici
result
impair
develop
matur
function
cell
correspond
previou
interestingli
percentag
cell
mpbl
mice
mice
transplant
howev
percentag
significantli
lower
mice
skin
transplant
fig
infiltr
number
cell
skin
graft
distinctli
lower
mice
skin
transplant
find
suggest
reduc
prolifer
activ
function
cell
mice
respons
allogen
antigen
cell
promin
compon
allogen
tcell
repertoir
induc
allogen
transplant
mice
cytotox
activ
direct
toward
donor
major
histocompat
complex
mhc
class
reduc
percentag
cell
mice
fig
allogen
transplant
may
partli
contribut
reduc
necrot
degre
graft
delay
allograft
reject
moreov
percentag
cell
msl
lower
mice
mice
transplant
differ
reduc
transplant
report
inhibit
increas
donor
cell
home
improv
allogen
decreas
percentag
differ
cell
msl
two
type
mice
transplant
may
due
increas
home
cell
spleen
mice
allograft
reject
primarili
driven
host
cell
compon
innat
adapt
immun
system
particip
graft
reject
lymphocyt
particular
cell
paramount
import
activ
cell
primarili
direct
progress
respons
secret
cytokin
activ
expand
andor
recruit
effector
cell
macrophag
cell
b
analysi
cytokin
level
type
mice
markedli
reduc
secret
found
serum
mice
allogen
transplant
fig
reduc
secret
may
caus
lower
number
cell
mice
transplant
howev
impair
differenti
function
cell
respons
allogen
antigen
mice
consid
low
serum
level
indic
partli
defect
differenti
function
cell
low
level
indic
insuffici
differenti
function
cell
mice
key
cytokin
exhibit
divers
potenti
contradictori
effect
organ
allograft
anoth
cytokin
also
complex
effect
allograft
pleiotrop
cytokin
play
import
role
prolifer
b
cell
inflammatori
reaction
cytokin
first
act
molecul
initi
tcell
growth
surviv
immun
respons
reinforc
respons
posit
acut
reject
cell
predominantli
infiltr
graft
induc
activ
nk
cell
macrophag
strong
weapon
destroy
furthermor
induc
express
class
ii
mhc
molecul
secret
activ
b
cell
acut
reject
model
mice
show
delay
skin
graft
sever
studi
report
toler
allograft
reject
mediat
least
part
typic
cytokin
cell
promot
studi
provid
conflict
result
indic
administr
inhibitor
prolong
cardiac
allograft
show
effect
similar
anoth
cytokin
associ
respons
share
receptor
chain
differ
target
cell
involv
result
seri
differ
biolog
increas
number
studi
demonstr
cytokin
cell
capabl
support
bcell
clonal
expans
antibodi
defici
result
impair
differenti
function
cell
mice
low
level
cytokin
could
result
decreas
prolifer
cell
fig
activ
macrophag
therebi
reduc
infiltr
cell
macrophag
graft
fig
allograft
reject
hand
low
level
mice
allogen
transplant
could
impair
activ
differenti
b
cell
reduc
antibodi
product
fig
immun
reject
complex
process
involv
cellular
well
humor
immun
respons
character
product
antibodi
b
lymphocyt
igg
main
compon
serum
ig
common
pathogen
antibodi
patient
transplant
reject
play
indispens
role
damag
graft
transplant
present
work
low
product
igg
subset
detect
serum
mice
fig
result
correspond
previou
find
demonstr
antibodi
product
clearli
lower
mice
mice
either
ovalbumin
immun
pokewe
mitogen
find
indic
differenti
b
cell
impair
defici
tcelldepend
bcell
activ
interact
b
cell
th
cell
certain
cytokin
requir
support
bcell
clonal
expans
antibodi
synthesi
mice
low
percentag
th
cell
fig
low
product
fig
could
lead
impair
activ
differenti
b
cell
thu
reduc
igg
product
igg
major
compon
mediat
allorecognit
exogen
antigen
recipi
cell
graft
low
igg
product
mice
fig
may
therefor
result
reduct
graft
attack
effector
cell
interestingli
secret
level
higher
mice
fig
support
result
blockad
shown
improv
lung
allograft
transplant
increas
express
known
antiinflammatori
cytokin
report
downregul
express
cytokin
inflamm
process
particularli
treg
cell
variou
cell
type
produc
includ
macrophag
well
regulatori
mice
high
level
secret
fig
might
result
high
percentag
treg
fig
notabl
respons
allogen
transplant
high
level
detect
serum
mice
first
day
peak
day
transplant
howev
small
amount
detect
serum
mice
day
transplant
fig
recent
studi
demonstr
play
import
role
regul
balanc
cell
thu
low
level
high
percentag
treg
observ
mice
studi
fig
could
partli
due
reduc
function
excess
activ
addit
report
human
cell
character
high
express
neg
select
marker
human
suggest
involv
differenti
function
cell
relat
treg
therefor
surpris
impair
balanc
differenti
treg
observ
mice
although
allograft
reject
tradit
associ
differenti
mani
recent
studi
show
cell
close
associ
allograft
cell
recent
addit
tcell
paradigm
key
cytokin
proinflammatori
accumul
evid
suggest
cell
play
role
develop
chronic
allograft
injuri
transplant
variou
organ
hallmark
cellmedi
allograft
reject
abil
recruit
neutrophil
one
first
inflammatori
effector
cell
capabl
infiltr
allograft
transplant
therebi
caus
allograft
convers
treg
play
crucial
role
immun
toler
neg
control
variou
immun
respons
suppress
downregul
effector
cell
immun
report
inhibit
promot
secret
essenti
differenti
develop
function
treg
cell
forkhead
transcript
factor
report
import
factor
maintain
high
level
observ
mice
fig
may
benefit
express
reduc
activ
increas
treg
percentag
msl
mpbl
mice
allogen
transplant
assum
import
reason
reduc
necrosi
graft
delay
allograft
reject
mice
certain
chemokin
contribut
infiltr
macrophag
graft
tissu
monocyt
chemotact
protein
macrophag
colonystimul
factor
mcsf
chemokin
ligand
rant
regul
normal
cell
express
secret
substrat
mcp
rant
truncat
dppiv
follow
alter
found
mcp
aminotermin
ly
cleav
may
result
inactiv
chemotaxi
howev
mcp
pglu
remain
effect
differ
isoform
mcp
involv
macrophag
chemotaxi
skin
transplant
investig
truncat
dppiv
report
decreas
bind
chemokin
receptor
increas
bind
contribut
macrophag
recruit
renal
defici
mice
like
reduc
activ
bind
result
reduct
macrophag
infiltr
graft
multifunct
protein
exhibit
either
enzymat
activ
interact
differ
molecul
recent
studi
report
involv
cutan
wound
heal
higher
rate
wound
closur
revascular
cell
prolifer
observ
mice
dppiv
inhibitor
show
potenti
benefit
wound
case
skin
transplant
involv
immun
reject
also
wound
heal
process
thu
play
januslik
role
engraft
reject
present
work
necrot
level
graft
level
igg
relat
cytokin
serum
mice
markedli
lower
mice
howev
day
posttransplant
graft
remov
wound
heal
quickli
mice
reduct
allograft
reject
mice
observ
present
work
may
partli
counteract
enhanc
wound
heal
involv
process
conclus
result
indic
involv
allogen
graft
reject
defici
result
partli
impair
differenti
subpopul
increas
percentag
treg
turn
reduc
function
affect
differenti
b
cell
decreas
activ
cell
macrophag
lead
lower
product
igg
delay
allograft
reject
mice
skin
transplant
complex
process
current
work
demonstr
defici
could
result
delay
allograft
reject
allogen
skin
transplant
underli
mechan
investig
elucid
activ
differenti
b
cell
macrophag
allogen
transplant
mice
influenc
activ
certain
chemokin
well
infiltr
macrophag
mechan
drive
treg
mice
addit
play
import
role
skin
transplant
wound
heal
extent
wound
heal
affect
graft
survivalreject
mice
allogen
skin
transplant
also
clarifi
